Maryam Borhani-Haghighi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Maryam Borhani-Haghighi has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Fatemeh Alipour
Shefa Neuroscience Research Center, Khatam Alanbia Hospital, Tehran, Iran
3 shared publicationsHoda Pasand Mojdeh
School of Biology, College of Science, University of Tehran, Tehran, Iran
3 shared publicationsYousef Mohamadi
Department of Anatomy, School of Medicine, Ilam University of Medical Sciences, Ilam, Islamic Republic of Iran
2 shared publications- Yousef Mohamadi
Department of Anatomical Sciences, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran
2 shared publications - Ali Gorji
A. Shefa Neuroscience Research Center, Khatam Alanbia Hospital, Tehran, Iran. b. Epilepsy Research Center, Department of Neurosurgery, Münster University, Münster, Germany
1 shared publication Ali Jahanbazi Jahan-Abad
Department of Clinical Biochemistry, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
1 shared publication
Latest Publications
- Retraction
- 26 July 2024
- Published by Elsevier in Journal of Chemical Neuroanatomy
- Vol. 139, 102445
Retraction notice to “TGN020 application against aquaporin 4 improved multiple sclerosis by inhibiting astrocytes, microglia, and NLRP3 inflammasome in a cuprizone mouse model” [J. Chem. Neuroanat. 132 (2023) 102306]
- 26 July 2024
- Published by Elsevier in Journal of Chemical Neuroanatomy
- Vol. 139, 102445
RetractionRetraction notice to “TGN020 application against aquaporin 4 improved multiple sclerosis by inhibiting astrocytes, microglia, and NLRP3 inflammasome in a cuprizone mouse model” [J. Chem. Neuroanat. 132 (2023) 102306]
- Retracted
- 1 July 2023
- Published by Elsevier in Journal of Chemical Neuroanatomy
- Vol. 132, 102306
RETRACTED: TGN020 application against aquaporin 4 improved multiple sclerosis by inhibiting astrocytes, microglia, and NLRP3 inflammasome in a cuprizone mouse model
- 1 July 2023
- Published by Elsevier in Journal of Chemical Neuroanatomy
- Vol. 132, 102306
RetractedRETRACTED: TGN020 application against aquaporin 4 improved multiple sclerosis by inhibiting astrocytes, microglia, and NLRP3 inflammasome in a cuprizone mouse model
- Open Access
- 30 April 2020
- Published by Asian Spine Journal (ASJ) in Asian Spine Journal
- Vol. 14 (2) , 131-138
The Therapeutic Potential of Conditioned Medium from Human Breast Milk Stem Cells in Treating Spinal Cord Injury
Study Design: Experimental animal study.Purpose: This study investigated the therapeutic effects of human breast milk stem cell (BMSC)-conditioned medium (BMSC-CM) in a model of spinal cord injury (SCI) in male Sprague-Dawley rats.Overview of Literature: SCI is one of the leading causes of disability in addition to sensory and motor impairment. So far, there have been no successful treatments for SCI. Given the positive outcomes associated with using stem cells and their derivatives as a treatment for various diseases, there is a growing interest in using them as an SCI treatment. Recent research has demonstrated that CM from stem cells has therapeutic advantages.Methods: Human BMSCs were isolated and characterized, and CM was subsequently collected. Animals received an intrathecal administration of BMSC-CM after SCI. The activity of caspase-3 was measured to assess apoptosis, and levels of tumor necrosis factor-α and interleukin-1β were measured to assess inflammation. Also, sensory and locomotor performances were assessed after SCI and BMSC-CM administration.Results: Administration of CM from BMSC reduced apoptosis and inflammation at the site of injury in a rat model of SCI (p<0.05). Motor, sensory, locomotor, and sensorimotor performances were significantly improved in rats that received BMSC-CM after SCI.Conclusions: Intrathecal administration of BMSC-CM improved recovery in a rat model of SCI.
- 30 April 2020
- Published by Asian Spine Journal (ASJ) in Asian Spine Journal
- Vol. 14 (2) , 131-138
Open AccessThe Therapeutic Potential of Conditioned Medium from Human Breast Milk Stem Cells in Treating Spinal Cord Injury
Study Design: Experimental animal study.Purpose: This study investigated the therapeutic effects of human breast milk stem cell (BMSC)-conditioned medium (BMSC-CM) in a model of spinal cord injury (SCI) in male Sprague-Dawley rats.Overview of Literature: SCI is one of the leading causes of disability in addition to sensory and motor impairment. So far, there have been no successful treatments for SCI. Given the positive outcomes associated with using stem cells and their derivatives as a treatment for various diseases, there is a growing interest in using them as an SCI treatment. Recent research has demonstrated that CM from stem cells has therapeutic advantages.Methods: Human BMSCs were isolated and characterized, and CM was subsequently collected. Animals received an intrathecal administration of BMSC-CM after SCI. The activity of caspase-3 was measured to assess apoptosis, and levels of tumor necrosis factor-α and interleukin-1β were measured to assess inflammation. Also, sensory and locomotor performances were assessed after SCI and BMSC-CM administration.Results: Administration of CM from BMSC reduced apoptosis and inflammation at the site of injury in a rat model of SCI (p<0.05). Motor, sensory, locomotor, and sensorimotor performances were significantly improved in rats that received BMSC-CM after SCI.Conclusions: Intrathecal administration of BMSC-CM improved recovery in a rat model of SCI.
- 1 October 2019
- Published by SAGE Publications in Cellular Reprogramming
- Vol. 21 (5) , 249-259
Human Menstrual Blood Stem Cell-Derived Granulosa Cells Participate in Ovarian Follicle Formation in a Rat Model of Premature Ovarian Failure In Vivo
We recently reported the application of human menstrual blood stem cells' (HuMenSCs) transplantation as a treatment modality in a rat model of premature ovarian failure (POF). We continued to investigate further in this respect. Female rats were injected intraperitoneally with 36 mg/kg busulfan. HuMenSCs were obtained, grown, and analyzed for immunophenotypic features at passage three. The cells were labeled with CM-Dil and infused into the rats. There were four groups: normal, negative control, treatment, and Sham. One month after treatment, the ovaries were collected and weighed. Histological sections were prepared from the ovary and HuMenSCs were tracking. Subsequently, we examined the changes of expression of Bax and B cell lymphoma 2 (Bcl2) genes by real-time polymerase chain reaction assay. One month after HuMenSCs transplantation, these cells were located in the ovarian interstitium and granulosa cells (GCs). The number of TUNEL-positive cells significantly decreased in the treatment group. Also the expression level of Bax genes, unlike Bcl2 gene, significantly decreased compared with negative and sham groups. In our study, HuMenSCs were tracked in ovarian tissues within 2 months after transplantation, and they differentiated into GCs. Therefore, the use of these cells can be a practical and low-cost method for the treatment of POF patients.
- 1 October 2019
- Published by SAGE Publications in Cellular Reprogramming
- Vol. 21 (5) , 249-259
Human Menstrual Blood Stem Cell-Derived Granulosa Cells Participate in Ovarian Follicle Formation in a Rat Model of Premature Ovarian Failure In Vivo
We recently reported the application of human menstrual blood stem cells' (HuMenSCs) transplantation as a treatment modality in a rat model of premature ovarian failure (POF). We continued to investigate further in this respect. Female rats were injected intraperitoneally with 36 mg/kg busulfan. HuMenSCs were obtained, grown, and analyzed for immunophenotypic features at passage three. The cells were labeled with CM-Dil and infused into the rats. There were four groups: normal, negative control, treatment, and Sham. One month after treatment, the ovaries were collected and weighed. Histological sections were prepared from the ovary and HuMenSCs were tracking. Subsequently, we examined the changes of expression of Bax and B cell lymphoma 2 (Bcl2) genes by real-time polymerase chain reaction assay. One month after HuMenSCs transplantation, these cells were located in the ovarian interstitium and granulosa cells (GCs). The number of TUNEL-positive cells significantly decreased in the treatment group. Also the expression level of Bax genes, unlike Bcl2 gene, significantly decreased compared with negative and sham groups. In our study, HuMenSCs were tracked in ovarian tissues within 2 months after transplantation, and they differentiated into GCs. Therefore, the use of these cells can be a practical and low-cost method for the treatment of POF patients.
- 12 March 2019
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 120 (8) , 12785-12795
In utero transplantation of neural stem cells ameliorates maternal inflammation‐induced prenatal white matter injury
Prenatal white matter injury is a serious problem due to maternal inflammation leading to postnatal disabilities. In this study, we used the periventricular leukomalacia (PVL) model as a common prenatal white matter injury by maternal administration of lipopolysaccharide (LPS). Neural stem cells (NSCs) have shown therapeutic ability in neurological disorders through a different mechanism such as immunomodulation. Here, we studied the preventive potential of NSCs following in utero transplantation into the embryonic lateral ventricle in an LPS‐induced white matter injury model. Pregnant animals were divided into three groups and received phosphate buffered saline, LPS, or LPS + NSCs. The brains of offspring were obtained and evaluated by real‐time polymerase chain reaction (PCR), immunohistochemy, enzyme‐linked immunosorbent assay (ELISA), terminal deoxynucleotidyl transferase‐mediated biotinylated‐dUTP nick‐end labeling (TUNEL), and caspase‐3 activity assay. The LPS‐induced maternal inflammation degenerated the myelin sheath in the offspring periventricular region which was associated with an increased microglial number, oligodendrocytes degeneration, proinflammatory cytokine secretion, and cell apoptosis. The transplanted NSCs homed into the brain and ameliorated the evaluated parameters. The expression of proinflammatory cytokines interleukin‐1β (IL‐1β), IL‐6, and tumor necrosis factor‐α (TNF‐α), cell apoptosis and caspase‐3 activity were inhibited by NSCs. In addition, Olig2 and myelin basic protein immunohistochemy staining showed that prenatal NSCs transplantation augmented the myelination in the periventricular white matter of offspring. In conclusion, we think that prenatal therapeutic strategies, such as in utero NSCs transplantation, may prevent prenatal white matter injury after birth.
- 12 March 2019
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 120 (8) , 12785-12795
In utero transplantation of neural stem cells ameliorates maternal inflammation‐induced prenatal white matter injury
Prenatal white matter injury is a serious problem due to maternal inflammation leading to postnatal disabilities. In this study, we used the periventricular leukomalacia (PVL) model as a common prenatal white matter injury by maternal administration of lipopolysaccharide (LPS). Neural stem cells (NSCs) have shown therapeutic ability in neurological disorders through a different mechanism such as immunomodulation. Here, we studied the preventive potential of NSCs following in utero transplantation into the embryonic lateral ventricle in an LPS‐induced white matter injury model. Pregnant animals were divided into three groups and received phosphate buffered saline, LPS, or LPS + NSCs. The brains of offspring were obtained and evaluated by real‐time polymerase chain reaction (PCR), immunohistochemy, enzyme‐linked immunosorbent assay (ELISA), terminal deoxynucleotidyl transferase‐mediated biotinylated‐dUTP nick‐end labeling (TUNEL), and caspase‐3 activity assay. The LPS‐induced maternal inflammation degenerated the myelin sheath in the offspring periventricular region which was associated with an increased microglial number, oligodendrocytes degeneration, proinflammatory cytokine secretion, and cell apoptosis. The transplanted NSCs homed into the brain and ameliorated the evaluated parameters. The expression of proinflammatory cytokines interleukin‐1β (IL‐1β), IL‐6, and tumor necrosis factor‐α (TNF‐α), cell apoptosis and caspase‐3 activity were inhibited by NSCs. In addition, Olig2 and myelin basic protein immunohistochemy staining showed that prenatal NSCs transplantation augmented the myelination in the periventricular white matter of offspring. In conclusion, we think that prenatal therapeutic strategies, such as in utero NSCs transplantation, may prevent prenatal white matter injury after birth.
- Open Access
- 1 April 2017
- Published by CASRP: Center of Advanced Scientific Research and Publications in The Neuroscience Journal of Shefaye Khatam
- Vol. 5 (2) , 88-97
Seladin-1: A Possible Neuroprotective Agent in Alzheimer's Disease
The Neuroscience Journal of Shefaye Khatam, (Shefaye Khatam) مجله علوم اعصاب شفای خاتم
- 1 April 2017
- Published by CASRP: Center of Advanced Scientific Research and Publications in The Neuroscience Journal of Shefaye Khatam
- Vol. 5 (2) , 88-97
Open AccessSeladin-1: A Possible Neuroprotective Agent in Alzheimer's Disease
The Neuroscience Journal of Shefaye Khatam, (Shefaye Khatam) مجله علوم اعصاب شفای خاتم
- 1 April 2017
- Published by CASRP: Center of Advanced Scientific Research and Publications in The Neuroscience Journal of Shefaye Khatam
- Vol. 5 (2) , 1-8
Expression of Hepatocyte Markers in Wharton’s Jelly Mesenchymal Stem Cells Using Mouse Liver Cell Extract
The Neuroscience Journal of Shefaye Khatam, (Shefaye Khatam) مجله علوم اعصاب شفای خاتم
- 1 April 2017
- Published by CASRP: Center of Advanced Scientific Research and Publications in The Neuroscience Journal of Shefaye Khatam
- Vol. 5 (2) , 1-8
Expression of Hepatocyte Markers in Wharton’s Jelly Mesenchymal Stem Cells Using Mouse Liver Cell Extract
The Neuroscience Journal of Shefaye Khatam, (Shefaye Khatam) مجله علوم اعصاب شفای خاتم
- Open Access
- 1 September 2016
- Published by CASRP: Center of Advanced Scientific Research and Publications in The Neuroscience Journal of Shefaye Khatam
- Vol. 4 (3) , 70-80
Alzheimer's Disease: Background, Current and Future Aspects
Introduction: Alzheimer's disease (AD) is described by structural and functional disturbances of the human brain. The amyloid fibril proteins are located and deposited inside neurons as neurofibrillary tangles. These are also deposited extracellular compartment as amyloid plaques. These changes are accompanied by the progressive disorder and loss of nerve cells ...
- 1 September 2016
- Published by CASRP: Center of Advanced Scientific Research and Publications in The Neuroscience Journal of Shefaye Khatam
- Vol. 4 (3) , 70-80
Open AccessAlzheimer's Disease: Background, Current and Future Aspects
Introduction: Alzheimer's disease (AD) is described by structural and functional disturbances of the human brain. The amyloid fibril proteins are located and deposited inside neurons as neurofibrillary tangles. These are also deposited extracellular compartment as amyloid plaques. These changes are accompanied by the progressive disorder and loss of nerve cells ...
- Open Access
- 1 June 2016
- Published by CASRP: Center of Advanced Scientific Research and Publications in The Neuroscience Journal of Shefaye Khatam
- Vol. 4 (2) , 87-97
The Role of Stem Cell Therapy in Alzheimer's Disease
Introduction: Alzheimer's disease (AD) is the most ordinary reason of dementia in old population. AD is a permanent and progressive brain disorder that gradually deteriorates memory and speaking skills, and eventually leads to disability to accomplish the effortless skills. In this disease, the brain cells are gradually destroyed and as a result, ...
- 1 June 2016
- Published by CASRP: Center of Advanced Scientific Research and Publications in The Neuroscience Journal of Shefaye Khatam
- Vol. 4 (2) , 87-97
Open AccessThe Role of Stem Cell Therapy in Alzheimer's Disease
Introduction: Alzheimer's disease (AD) is the most ordinary reason of dementia in old population. AD is a permanent and progressive brain disorder that gradually deteriorates memory and speaking skills, and eventually leads to disability to accomplish the effortless skills. In this disease, the brain cells are gradually destroyed and as a result, ...